来自非小细胞肺癌的大脑转移:癌细胞和瘤微环境组件之间的交叉声
Myung-Seo Kim1,2, Juyoun Lee3, Jeong Eun Lee4
1Department of Pathology, Translational Immunology Institute, Chungnam National University School of Medicine, Daejeon, Republic of Korea.
Experimental & molecular medicine
|December 22, 2025
概括
晚期肺癌的大脑转移 (BMs) 由于血脑屏障,难以治疗. 了解脑瘤微环境 (TME) 是开发肺癌脑转移新疗法的关键.
科学领域:
- 在瘤学瘤学.
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
背景情况:
- 晚期肺癌经常出现大脑转移 (BM),导致患者患病率显著.
- 目前对BMs的治疗面临挑战,原因是血脑屏障和获得的遗传抵抗力.
- 非小细胞肺癌 (NSCLC) 表现出遗传多样性,影响治疗策略.
研究的目的:
- 审查NSCLC脑转移中的脑特异性瘤微环境 (TME).
- 探索瘤细胞如何利用大脑TME进行转移殖民.
- 突出了解瘤-TME相互作用对于治疗开发的重要性.
主要方法:
- 文献综述专注于NSCLC的大脑转移.
- 分析NSCLC细胞与大脑TME之间的相互作用.
- 检查转移性利基中的分子相互作用和免疫调节.
主要成果:
- 通过特定的分子和免疫机制,NSCLC细胞适应大脑转移的利基.
- 大脑TME在BMs的建立和进展中发挥着关键作用.
- 免疫疗法在增强TME内的抗瘤免疫力方面显示出前景.
结论:
- 了解NSCLC细胞和大脑TME之间的复杂交叉通话是至关重要的.
- 针对BM的向治疗策略需要对大脑特异性转移机制有更深入的了解.
- 进一步研究大脑TME对于改善患有BMs的肺癌患者的治疗结果至关重要.
更多相关视频
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K


